Chang Shu Wang

1.3k total citations
15 papers, 565 citations indexed

About

Chang Shu Wang is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Chang Shu Wang has authored 15 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Otorhinolaryngology. Recurrent topics in Chang Shu Wang's work include Cancer Cells and Metastasis (4 papers), Head and Neck Cancer Studies (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Chang Shu Wang is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Head and Neck Cancer Studies (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Chang Shu Wang collaborates with scholars based in Canada. Chang Shu Wang's co-authors include A. Fortin, Bernard Têtu, Éric Vigneault, Jacques Brisson, Caty Blanchette, Hélène Lapointe, Dominique Trudel, Isabelle Bairati, Geoffrey Liu and François Meyer and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Chang Shu Wang

15 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Shu Wang Canada 12 241 173 146 139 124 15 565
Maria Gonidi Greece 11 146 0.6× 137 0.8× 76 0.5× 187 1.3× 51 0.4× 29 466
Sophia Bornstein United States 9 433 1.8× 93 0.5× 166 1.1× 441 3.2× 43 0.3× 17 819
Jianfeng Wu China 12 75 0.3× 107 0.6× 126 0.9× 214 1.5× 81 0.7× 43 520
Mitsunori Higuchi Japan 14 275 1.1× 250 1.4× 67 0.5× 126 0.9× 21 0.2× 77 654
Su Mei Cao China 6 281 1.2× 86 0.5× 137 0.9× 173 1.2× 243 2.0× 19 586
Jolanta Szelachowska Poland 12 247 1.0× 61 0.4× 113 0.8× 208 1.5× 18 0.1× 34 508
Ming‐Huang Hong China 15 240 1.0× 216 1.2× 112 0.8× 117 0.8× 391 3.2× 17 640
Ghassan Allo Canada 16 194 0.8× 172 1.0× 227 1.6× 334 2.4× 34 0.3× 29 796
Sai‐Lan Liu China 15 314 1.3× 231 1.3× 190 1.3× 241 1.7× 383 3.1× 55 752
Willa Shi Canada 7 238 1.0× 113 0.7× 150 1.0× 200 1.4× 237 1.9× 7 563

Countries citing papers authored by Chang Shu Wang

Since Specialization
Citations

This map shows the geographic impact of Chang Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Shu Wang more than expected).

Fields of papers citing papers by Chang Shu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Shu Wang. The network helps show where Chang Shu Wang may publish in the future.

Co-authorship network of co-authors of Chang Shu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Shu Wang. A scholar is included among the top collaborators of Chang Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Shu Wang. Chang Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lévesque, Dominique, François‐Michel Boisvert, Chang Shu Wang, et al.. (2022). Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy. Cancer Immunology Immunotherapy. 72(5). 1089–1102. 25 indexed citations
2.
Meyer, François, A. Fortin, Chang Shu Wang, Geoffrey Liu, & Isabelle Bairati. (2011). Predictors of Severe Acute and Late Toxicities in Patients With Localized Head-and-Neck Cancer Treated With Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1454–1462. 86 indexed citations
3.
Fortin, A., Chang Shu Wang, & Éric Vigneault. (2008). Effect of Pretreatment Anemia on Treatment Outcome of Concurrent Radiochemotherapy in Patients With Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). 255–260. 14 indexed citations
4.
Fortin, A., et al.. (2008). A Comparison of Treatment Outcomes by Radiochemotherapy and Postoperative Radiotherapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck. American Journal of Clinical Oncology. 31(4). 379–383. 3 indexed citations
5.
Fortin, A., Chang Shu Wang, & Éric Vigneault. (2008). Influence of Smoking and Alcohol Drinking Behaviors on Treatment Outcomes of Patients With Squamous Cell Carcinomas of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1062–1069. 86 indexed citations
6.
Têtu, Bernard, Jacques Brisson, Chang Shu Wang, et al.. (2006). The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Research. 8(3). R28–R28. 109 indexed citations
7.
Têtu, Bernard, Dominique Trudel, & Chang Shu Wang. (2006). [Proteases by reactive stromal cells in cancer: an attractive therapeutic target].. PubMed. 93(9). 944–8. 10 indexed citations
8.
Laverdière, Jacques, Abdenour Nabid, Annie Ébacher, et al.. (2004). The Efficacy and Sequencing of a Short Course of Androgen Suppression on Freedom From Biochemical Failure When Administered With Radiation Therapy for T2-T3 Prostate Cancer. The Journal of Urology. 171(3). 1137–1140. 98 indexed citations
9.
Wang, Chang Shu & Bernard Têtu. (2002). Stromelysin‐3 expression by mammary tumor‐associated fibroblasts under in vitro breast cancer cell induction. International Journal of Cancer. 99(6). 792–799. 21 indexed citations
10.
Wang, Chang Shu, Francine Goulet, François A. Auger, et al.. (2001). PRODUCTION OF BIOENGINEERED CANCER TISSUE CONSTRUCTS IN VITRO: EPITHELIUM–MESENCHYME HETEROTYPIC INTERACTIONS. In Vitro Cellular & Developmental Biology - Animal. 37(7). 434–434. 6 indexed citations
11.
Wang, Chang Shu, Francine Goulet, Nathalie Tremblay, et al.. (2001). Selective Culture of Epithelial Cells from Primary Breast Carcinomas Using Irradiated 3T3 Cells as Feeder Layer. Pathology - Research and Practice. 197(3). 175–181. 15 indexed citations
12.
Brisson, Jacques, et al.. (2001). Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis. Cancer. 92(11). 2957–2964. 16 indexed citations
13.
Wang, Chang Shu, Francine Goulet, Josée N. Lavoie, et al.. (2000). Establishment and Characterization of a New Cell Line Derived from a Human Primary Breast Carcinoma. Cancer Genetics and Cytogenetics. 120(1). 58–72. 35 indexed citations
14.
Têtu, Bernard, Jacques Brisson, Hélène Lapointe, et al.. (1999). Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases. Breast Cancer Research and Treatment. 55(2). 135–145. 19 indexed citations
15.
Wang, Chang Shu, et al.. (1997). mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy. Breast Cancer Research and Treatment. 45(1). 63–74. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026